Hot COVID-19
Home >Products> Microarrays | Software >Biochip> High Throughput Tissue Microarray
Microarrays | Software:  Biochip   Spotters / Scanning Apparatus   Biology Software  
High Throughput Tissue Microarray
High Throughput Tissue Microarray
Place of Origin:
China
Brand:
Model:
Other ( Parts as follow )
Price:
Hits:
2826 
Updated:
1/9/2008
  • Product Detail
  • Company Profile

    Catalog

    Description

    Dots

    Cases

    Remark

    OD-CT-DgLiv01-001

    Hepatic carcinoma

    478

    245

    Multi-pathological types

    OD-CT-DgPan02-001

    Pancreatic carcinoma

    289

    167

    Multi-pathological types

    OD-CT-DgCom01-001

    Gastrointestinal carcinoma

    342

    59

    Single Carcinoma

    OD-CT-DgStm01-001

    Gastric carcinoma

    86

    29

    CarcinomaMarginNormal

    OD-CT-DgCol01-001

    Colon carcinoma

    104

    44

    CarcinomaMarginNormal

    OD-CT-DgRec01-001

    Rectum carcinoma

    130

    39

    CarcinomaMarginNormal

    OD-CT-NHCom01-001 Normal tissue 46 23 Multi-organs

     

     

     

     

     

     

     

     

    bio-equip.cn
    Shanghai Outdo Biotech Co.Ltd. (Outdo Biotech) is a leading company in human/animal Tissue Microarrays (TMA) and “Clinical-Type” Gene Chip (CTGC) in China. Our shareholders are Shanghai Biochip Co., Ltd. & National Engineering Center for Biochip at Shanghai, Shanghai Cancer Institute and Eastern Liver and Bladder Hospital of Second Military Medical University.

    TMA is a mean of combining tens to hundreds of specimens of tissue, paraffin embedded or frozen, onto a single slide for analysis at once. Our construction of TMAs is flexible and helps meet the needs of our customers. A TMA slide is processed like an ordinary tissue section, and then used for histochemical, immuno-histochemical staining, in-situ hybridization and FISH. Combined with highly automated image analysis system, TMA is a high-throughput molecular profiling tool for parallel analysis of biological and molecular characteristics for specimens of pathological tissues. TMA technology also provides a platform for the efficient locating and evaluating of protein, RNA, DNA molecules in various tissues and is particularly useful for functional genomic studies.

    TMA is commonly used to confirm the results of expression Microarrays as well as in the development of diagnostic and prognostics markers for clinical applications. TMA makes use of vast amount of archived paraffin embedded tissue and makes them accessible for medical and academic research. TMA is playing an ever increasing role in translational medicine, bridging the gap of discovery at the research bench to clinical utility implementation in patient care.

    Our company now has three sets of newly developed high throughput tissue microarray products available such as Cat100, Cat.200 and Cat.500, including liver carcinoma, gastric carcinoma, lung carcinoma, esophagus carcinoma, kidney carcinoma, breast carcinoma, pancreas carcinoma and so on.We can design tissue microarrays according to the needs of customers with the tissue specimens provided by our tissue bank or the customers.

    We also has developed two CTGC products including HBV YMDD Mutation Detection Gene Array Kit for detection of patients with Lamivudine resistance and Interleukin-1B Mutation Detection Gene Array Kit for detection of hosts with H. pylori infection susceptibility to gastric cancer.



Request Infomation
Request Infomation: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Infomation

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Infomation:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.